The Pre-Heart Failure in Hypertension

The objectives of this study were to detect pre-heart failure based on NT-proBNP in subjects with hypertension and identify the risk factors for failure. Research methods: We conducted a cross -sectional between August December 2022. This was included 526 aged from 35- 64 years, who had no clinical symptoms heart Cardiovascular detected by examinations laboratory test. Hypertension defined as systolic BP ≥ 130 mm Hg, diastolic 80 and/or receiving treatment anti-hypertensive agents. NT-pro BNP determination performed an immunoassay analyzer (Getein 1100). An elevated 125pg/ml. Pre-heart BNPlevel. Ethical statement ethical permission obtained Biomedical Ethics Committee Mongolian National University Medical Sciences. results: In total, hypertensive s 35-64 year enrolled study, which, 243 (46.2%) men mean age 52.5±7.7 years. prevalence women non-significantly higher than men(17.3% vs 14.0%, p= 0.297). increased 4.0% 35-44 years 20.9% 55-64 Based our logistic regression analysis, likelihood independently associated age(OR 2.18, 95%CI 1.51-3.14) poor blood pressure control(OR 2.41, 1.29-4.50). Conclusion: present showed that overall 15.8% age. control ageing significant development hypertension.